<DOC>
	<DOCNO>NCT02979795</DOCNO>
	<brief_summary>Rectal cancer , comprise 30 % overall colorectal cancer cohort , one lead cancer Taiwan . In patient advanced disease , standard care concurrent chemoradiotherapy ( CCRT ) surgery . After CCRT , abscopal effect , phenomenon localize radiation destroy local tumor also inhibit growth tumor remote site , observe . This effect believe associated tumor immune response . In addition , immune checkpoint molecule , Programmed cell death-1 ( PD-1 ) , Programmed cell death ligand-1 ( PD-L1 ) , Cytotoxic T-Lymphocyte Associated Protein 4 ( CTLA-4 ) , report associate therapeutic outcome . However , CCRT , 50 % patient still either persistent disease develop distant metastasis . To improve therapeutic outcome patient rectal cancer , project , thus , aim explore evolution factor may affect abscopal effect immune checkpoint function tissue blood CCRT .</brief_summary>
	<brief_title>Translational Research Identifying Molecular Mechanisms Rectal Cancer Metastasis</brief_title>
	<detailed_description>For patient , preoperative chemoradiotherapy result clinically tumor regression , degree response varies among patient . There approximately 40-60 % LARC patient treat CCRT achieve degree pathologic response . However , yet effective method commencement CCRT predict patient respond CCRT subsequently render good survival . Identify patent benefit CCRT crucial lower treatment-related morbidity sustain local control also improve survival rate LARC .</detailed_description>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<criteria>Rectal cancer patient China Medical University Hospital ( Age limit : 20 yr old ) Pregnancy , Disabilities</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>